Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,133,000 | 3,482,000 | 8,524,000 | 2,919,000 | 1,888,000 |
| Receivables | 9,486,000 | 9,297,000 | 9,427,000 | 8,919,000 | 8,892,000 |
| Inventories | 5,655,000 | 5,664,000 | 5,634,000 | 5,722,000 | 5,668,000 |
| Other current assets | 1,721,000 | 1,766,000 | 1,644,000 | 1,739,000 | 1,652,000 |
| TOTAL | $19,995,000 | $20,209,000 | $25,229,000 | $19,299,000 | $18,100,000 |
| Non-Current Assets | |||||
| PPE Net | 9,292,000 | 9,354,000 | 9,280,000 | 8,628,000 | 8,529,000 |
| Intangibles | 60,710,000 | 61,112,000 | 58,638,000 | 58,301,000 | 59,644,000 |
| Other Non-Current Assets | 4,108,000 | 3,983,000 | 4,007,000 | 4,308,000 | 4,306,000 |
| TOTAL | $74,110,000 | $74,449,000 | $71,925,000 | $71,237,000 | $72,479,000 |
| Total Assets | $94,105,000 | $94,658,000 | $97,154,000 | $90,536,000 | $90,579,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,814,000 | 6,122,000 | 5,579,000 | 1,010,000 | 1,010,000 |
| Accounts payable and accrued liabilities | 2,423,000 | 2,798,000 | 3,381,000 | 2,471,000 | 2,586,000 |
| Accrued Expenses | 4,285,000 | 4,302,000 | 5,449,000 | 5,070,000 | 4,679,000 |
| TOTAL | $14,112,000 | $15,884,000 | $17,010,000 | $11,118,000 | $10,997,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,194,000 | 29,135,000 | 28,909,000 | 28,150,000 | 29,250,000 |
| Deferred Revenues | 2,590,000 | 2,662,000 | 2,601,000 | 2,567,000 | 2,722,000 |
| Other Non-Current Liabilities | 3,879,000 | 4,054,000 | 4,068,000 | 4,223,000 | 4,356,000 |
| TOTAL | $36,078,000 | $36,341,000 | $35,996,000 | $35,691,000 | $37,111,000 |
| Total Liabilities | $50,190,000 | $52,225,000 | $53,006,000 | $46,809,000 | $48,108,000 |
| Shareholders' Equity | |||||
| Common Shares | 441,000 | 441,000 | 441,000 | 440,000 | 440,000 |
| Retained earnings | 44,289,000 | 43,064,000 | 41,910,000 | 40,452,000 | 39,074,000 |
| Other shareholders' equity | -2,924,000 | -3,054,000 | -3,099,000 | -2,928,000 | -2,724,000 |
| TOTAL | $43,752,000 | $42,257,000 | $43,978,000 | $43,549,000 | $42,293,000 |
| Total Liabilities And Equity | $93,942,000 | $94,482,000 | $96,984,000 | $90,358,000 | $90,401,000 |